Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ('Kelun-Biotech' or the 'Company', 6990.HK) and Harbour BioMed (HKEX: 02142) today announced that the National Medical Products Administration (NMPA) ...

Preclinical research across multiple cancer types now shows that the NAD+ salvage pathway, the same biological mechanism targeted by popular anti-aging supplements like nicotinamide mononucleotide ...

Researchers have uncovered a surprising molecular chain reaction in the brain that may play a role in some forms of autism.

Management attributes long-term value potential to the AlloSCOPE platform, which aims to solve the 'elephant in the room' of ...

Moby Strategic Execution and Operational Transformation. Achieved 137% year-over-year revenue growth in Q4 driven by bro ...

RASolute 302 Phase 3 catalyst, cash runway, and valuation risks for daraxonrasib. Read more macro analysis here.

A new experimental drug is showing remarkable promise for children with Dravet syndrome, a severe genetic form of epilepsy. In clinical trials, the treatment zorevunersen cut seizures by as much as 91 ...

A new study discovers how nitric oxide triggers a biochemical domino effect in the brain, leading to mTOR overactivation in ...

Study finds pigmented japonica rice like black and green varieties contain bioactive lipids and show slower starch digestion ...

Sepsis remains a major challenge in modern medicine, claiming millions of lives each year. For decades, clinical management has largely focused on suppressing excessive inflammation.

Neuroscientists propose a new theory of brain development where cells organize based on lineage rather than long-range signals.

Microplastics and nanoplastics are increasingly recognized as pervasive environmental contaminants that accumulate in animals ...